Medical Marijuana, Inc. Reports $7.8 Million in Net Revenue in 2022 Second Quarter Financial and Operational Results
SAN DIEGO, CA, Aug. 18, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands, and supply chain, announced its financial results for the quarter ending June 30, 2022, and provided an overview of recent operational highlights. Second Quarter 2022 Financial and Operational Highlights ● Generated $7.8 million in net revenue in the second quarter of 2022; ● Gross profit for the period ending June 30, 2022, was $6 million; ● Gross margins for the period were 76%; a substantial increase over the same period last year; ● International operations continued to experience growth with new revenue milestones ● The Company focused on its pharmaceutical initiatives r...